GE HealthCare Technologies Inc. is seeing a significant rise in its stock price, fueled by strategic decisions and positive market sentiment.
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is up 2.43%, closing at CA$67.34. This increase follows recent strategic announcements that have boosted investor confidence.
Investor takeaway: Investors are optimistic about GE HealthCare's focus on growth through acquisitions and advancements in medical technology, even with some financial concerns lingering.
Advertisement
GE HealthCare Technologies Inc.
GEHC.US
GEHC.US
GE HealthCare Technologies Inc.
WealthAwesomeMarket cap
$29.69B
P/E
15.1x
Div. yield
0.22%
Div. / share
$0.14
52W high
$89.64
52W low
$58.72
1W change
+2.26%
Beta
0.85
Analyst Price Targets
Based on 21 analysts covering GEHC · as of Oct 12, 2026
Wall Street analysts forecast GEHC stock price to rise 26.1% over the next 12 months.
Consensus
Buy4.24 / 5.00
Avg. Target
C$82.90
+26.1% Upside
Current Price
C$65.74
Last close
Analyst Breakdown (21 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GEHC's historical volatility
30-Day Vol
21.2%
Annualized
90-Day Vol
34.9%
Annualized
Trend (90d)
+0.5%
Annualized drift
90d Mean
C$65.86
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$65.78 | C$61.15 – C$70.76 |
| 60 trading days | C$65.82 | C$59.36 – C$72.98 |
| 90 trading days | C$65.86 | C$58.03 – C$74.73 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
2.43% Increase in Stock Price
GE HealthCare's stock has climbed to CA$67.34, reflecting investor confidence driven by strategic acquisitions and product approvals.
Bull case
The recent acquisition of Sofie Biosciences for $945 million is expected to strengthen GE HealthCare's position in the pharmaceutical diagnostics market, which could lead to future revenue growth. Additionally, the company has received CE Mark approval for its Photonova Spectra scanner, allowing it to tap into new sales channels in Europe.
Bear case
Despite these positive developments, GE HealthCare faces challenges with rising costs and concerns about organic revenue growth. The market remains cautious, with analysts predicting only modest growth in the upcoming year.
Strategic Acquisitions Boost Growth Potential
Advertisement
GE HealthCare's announcement to acquire Sofie Biosciences for $945 million is a key move aimed at enhancing its pharmaceutical diagnostics segment. This acquisition is expected to improve market access and expand product offerings, especially in radiopharmaceuticals.
Product Approvals Open New Market Opportunities
The CE Mark approval for GE HealthCare's Photonova Spectra photon-counting CT scanner is another encouraging development. This certification enables the company to expand its sales into European markets, potentially increasing revenues as demand for advanced imaging solutions rises.
Financial Health and Market Sentiment
While GE HealthCare is enjoying positive stock movement today, investors should keep in mind the company's financial challenges. Rising costs and the need for organic revenue growth are concerns that could affect future performance. Analysts note that while the stock appears attractively valued now, long-term growth will rely on the successful integration of acquisitions and effective cost management.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
